Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer

INTRODUCTION: Tumors that express estrogen receptor alpha (ERα+) comprise 75% of breast cancers in women. While treatments directed against this receptor have successfully lowered mortality rates, many primary tumors initially or later exhibit resistance. The paucity of murine models of this "l...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Arendt, Lisa M, Rugowski, Debra E, Grafwallner-Huseth, Tara A, Garcia-Barchino, Maria Jose, Rui, Hallgeir, Schuler, Linda A
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2011
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3109579/
https://ncbi.nlm.nih.gov/pubmed/21276249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2819
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars